Landen CN, Buckanovich RJ, Sill MW, Mannel RS, et al. Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. J Clin Oncol 2024 May 22:JCO2302076. doi: 10.1200/JCO.23.02076.
PMID: 38776484